This is for clinical research study crispr-based genome editing service to generate PC12 cell lines with snap and halo-tag sinserted at endogenous loci of VAMP2 and SYNTAXIN1A. Includes guide RNA…
Ended Purchase Order Awarded
- Contract number
- 75N95A25P00106
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,478
Award facts
- Contract value 100% obligated
- $23,478.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 6 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award from the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Genscript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey. The contract is for a CRISPR-based genome editing service to generate PC12 cell lines with SNAP and HALO-TAG inserted at endogenous loci of VAMP2 and SYNTAXIN1A. The contract has a ceiling value of $23,478.06 and is a firm fixed price purchase order. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that specializes in advanced molecular biology services for federal agencies, particularly in the life sciences and biomedical research domains. The company has established itself as a critical vendor for federal research institutions, holding multiple contract awards and a significant blanket purchase agreement with the USDA for SARS-CoV-2 surrogate virus neutralization test kits.
Description
This is for clinical research study crispr-based genome editing service to generate PC12 cell lines with snap and halo-tag sinserted at endogenous loci of VAMP2 and SYNTAXIN1A. Includes guide RNA design, donor synthesis, transfection, clonal screenin
Quick answers
Who was awarded contract 75N95A25P00106?
75N95A25P00106 was awarded to Genscript USA Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on August 14, 2025.
How much is contract 75N95A25P00106 worth?
The government has obligated $23,478 on 75N95A25P00106.
Was contract 75N95A25P00106 competed?
The extent of competition for 75N95A25P00106 was competed under sap. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award